Global Market Access & Pricing Lead, Early Neurology

Job title:

Global Market Access & Pricing Lead, Early Neurology

Location:

Cambridge, MA / Morristown, NJ (Hybrid with 3 days per week in-office requirement and 20% travel expected)

The Neurology Franchise at Sanofi is at the forefront of transforming the lives of patients with neurological conditions, with a particular focus on Alzheimer's Disease, one of the most challenging and urgent unmet medical needs of our time. As we build and advance our portfolio of Phase 2 assets in Alzheimer's Disease, we are creating a dynamic, cross-functional environment where innovation meets commercial excellence to bring hope to millions of patients and families worldwide.

The Global Market Access & Pricing Lead, Early Neurology provides an exceptional opportunity to shape the pricing and market access strategy for our emerging Alzheimer's Disease (ALZ) portfolio from the ground up. You will work at the intersection of science and business, collaborating across Global Development, Medical, Commercial, New Product Planning, Health Economics & Outcomes Research, Corporate Affairs, and key markets to fully realize the pricing and access potential of Sanofi's ALZ portfolio.

You will also lead additional projects and work streams related to neurodegenerative conditions beyond ALZ, including assessing business development opportunities. This position sits within the Global Market Access & Pricing Neurology Team, part of the Specialty Care Global Market Access organization, where collaboration, patient-centricity, and scientific rigor drive everything we do. The role is highly strategic - you will be part of a team that values bold thinking and is committed to delivering breakthrough treatments to patients who need them most.

Join the team transforming care for people with immune challenges, rare diseases, cancers, and Specialty Care neurological conditions. In Specialty Care, you’ll help deliver breakthrough treatments that bring hope to patients with some of the highest unmet needs.

We’re an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. Our deep understanding of the immune system and innovative pipeline enables us to invent medicines and vaccines that treat and protect millions of people around the world. Together, we chase the miracles of science to improve people’s lives.

• Lead value assessment of Sanofi's ALZ / neurodegenerative diseases assets and external opportunities
• Recommend price and access assumptions across key markets to support forecasts, business cases, and investment decisions (including target product indication, patient population, and product label)
• Develop compelling payer value propositions and early market access plans and strategies, with strong focus on competitive differentiation and scenario planning
• Actively contribute to Clinical Development Plans and Integrated Evidence Generation Plans to address payer needs in line with the target value proposition, access opportunities, risks, and mitigation strategies
• Play a key role in shaping the ALZ ecosystem in collaboration with Public Affairs and other business partners to drive value recognition of Sanofi's assets by payers by the time of launch, aiming for sustainable access to innovation
• Actively contribute to the Early Neurology Global Market Access Sub-Team, a cross-asset market access forum that brings together global and local market access teams from key markets to review payer and market insights, and co-create strategies
• Serve as a core member of Global Project Teams and Commercial platforms, contributing to the formulation and execution of asset strategy and playing an active role in preparing governance meetings (TARC, DWG, IDCC)
• Act as a subject matter expert and strategic partner to the business, delivering payer insights through robust market research, advisory boards, early scientific advice, and other platforms to help drive strategic and investment decisions
• Maintain a high level of knowledge regarding scientific, clinical, and commercial developments relevant to the assets under scope as well as key competitors

Requ…